|By PR Newswire||
|August 6, 2014 07:00 AM EDT||
MINNEAPOLIS, Aug. 6, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that it will participate in the Canaccord Genuity 34th Annual Growth Conference on Wednesday, August 13.
Rob Kill, President and CEO, will present at 5:00pm ET and meet with investors one on one at the conference at the Intercontinental Hotel Boston. Attendance at the conference is by invitation only. A live webcast of the presentation with accompanying slides will be broadcast via the Internet. Those interested in joining the webcast may access it through Uroplasty's website at www.uroplasty.com. An archived replay of the presentation will be available for 90 days following the event.
About Uroplasty, Inc.
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a global medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions. Our focus is the continued commercialization of our Urgent® PC Neuromodulation System, the only commercially available, FDA-cleared system that delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder (OAB). OAB is a chronic condition that affects approximately 42 million U.S. adults. The symptoms include urinary urgency, frequency and urge incontinence. We also offer Macroplastique®, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. For more information on the company and its products, please visit Uroplasty, Inc. at www.uroplasty.com.
For Further Information:
Brett Reynolds, SVP and CFO
Doug Sherk (Investors)/Janine McCargo (Business Media)
SOURCE Uroplasty, Inc.
Sep. 26, 2016 08:00 PM EDT Reads: 2,850
Sep. 26, 2016 07:30 PM EDT Reads: 287
Sep. 26, 2016 06:30 PM EDT Reads: 2,133
Sep. 26, 2016 05:15 PM EDT Reads: 1,586
Sep. 26, 2016 05:15 PM EDT Reads: 2,592
Sep. 26, 2016 05:00 PM EDT Reads: 1,831
Sep. 26, 2016 05:00 PM EDT Reads: 2,719
Sep. 26, 2016 04:30 PM EDT Reads: 1,619
Sep. 26, 2016 04:30 PM EDT Reads: 3,361
Sep. 26, 2016 04:30 PM EDT Reads: 2,111
Sep. 26, 2016 04:15 PM EDT Reads: 1,031
Sep. 26, 2016 04:00 PM EDT Reads: 2,529
Sep. 26, 2016 03:45 PM EDT Reads: 2,919
Sep. 26, 2016 03:30 PM EDT Reads: 1,559
Enterprise IT has been in the era of Hybrid Cloud for some time now. But it seems most conversations about Hybrid are focused on integrating AWS, Microsoft Azure, or Google ECM into existing on-premises systems. Where is all the Private Cloud? What do technology providers need to do to make their offerings more compelling? How should enterprise IT executives and buyers define their focus, needs, and roadmap, and communicate that clearly to the providers?
Sep. 26, 2016 03:00 PM EDT Reads: 1,557